Kinnate Biopharma Inc.

NasdaqGS:KNTE Stock Report

Market Cap: US$125.1m

Kinnate Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of KNTE?
Owner TypeNumber of SharesOwnership Percentage
Private Companies10,6360.0225%
Individual Insiders154,3780.327%
Hedge Funds2,601,6475.51%
General Public7,992,62716.9%
Institutions14,737,98431.2%
VC/PE Firms21,728,04046%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 80.27% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
29.1%
Foresite Capital Management, LLC
13,718,311US$36.4m3.95%8.16%
17%
OrbiMed Advisors LLC
8,009,729US$21.2m0%0.3%
5.51%
Tang Capital Management, LLC
2,601,647US$6.9m0%0.64%
4.67%
Vida Ventures Advisors, LLC
2,207,772US$5.9m0%2.28%
4.23%
Lynx1 Capital Management LP
1,997,006US$5.3m0%1.29%
3.85%
Viking Global Investors LP
1,820,462US$4.8m0%0.02%
2.21%
The Vanguard Group, Inc.
1,042,910US$2.8m4.9%no data
1.76%
Acadian Asset Management LLC
830,493US$2.2m12.7%0.01%
1.24%
BlackRock, Inc.
586,688US$1.6m-20.9%no data
1.22%
Renaissance Technologies LLC
574,979US$1.5m13.6%no data
1.2%
Millennium Management LLC
564,932US$1.5m1.38%no data
1.19%
Group One Trading LP, Asset Management Arm
563,565US$1.5m188,000%0.04%
0.99%
BML Capital Management, LLC
468,210US$1.2m0%0.86%
0.88%
Citadel Advisors LLC
415,842US$1.1m-60.8%no data
0.75%
Susquehanna International Group, LLP, Asset Management Arm
354,569US$939.6k144%no data
0.72%
GSA Capital Partners LLP
338,986US$898.3k-9.43%0.07%
0.63%
Two Sigma Investments, LP
299,633US$794.0k118%no data
0.61%
Acuitas Investments, LLC
289,766US$767.9k0%0.27%
0.49%
Geode Capital Management, LLC
230,753US$611.5k4.17%no data
0.47%
Pale Fire Capital SE
220,555US$584.5k214%0.08%
0.41%
Marshall Wace LLP
194,468US$515.3k131%no data
0.33%
Goldman Sachs Group, Investment Banking and Securities Investments
156,226US$414.0k97.8%no data
0.32%
Two Sigma Advisers, LP
153,000US$405.5k43%no data
0.32%
D. E. Shaw & Co., L.P.
150,695US$399.3k170%no data
0.24%
Dws Investment Gmbh
114,846US$304.3k0%no data